Georgia Healthcare Group PLC (LON:GHG)‘s stock had its “buy” rating reiterated by analysts at Numis Securities Ltd in a research report issued on Monday. They presently have a GBX 355 ($4.39) price objective on the stock. Numis Securities Ltd’s target price would indicate a potential upside of 16.78% from the company’s current price.
Several other research firms also recently commented on GHG. Investec assumed coverage on shares of Georgia Healthcare Group PLC in a research report on Wednesday, October 5th. They issued a “buy” rating and a GBX 361 ($4.47) target price for the company. Jefferies Group reissued a “buy” rating and issued a GBX 280 ($3.47) target price on shares of Georgia Healthcare Group PLC in a research report on Monday, July 25th.
Shares of Georgia Healthcare Group PLC (LON:GHG) opened at 304.00 on Monday. Georgia Healthcare Group PLC has a 12 month low of GBX 145.00 and a 12 month high of GBX 350.00. The company’s 50 day moving average is GBX 298.25 and its 200-day moving average is GBX 264.28. The company’s market cap is GBX 389.67 million.
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.